Growth Metrics

Dexcom (DXCM) Share-based Compensation Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.69%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 3.57%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -4.08%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 12.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 12.94%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 26.61%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 59.09%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 31.63%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 23.47%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 26.61%
Dec 31, 2025 -19.17%
Sep 30, 2025 3.92%
Jun 30, 2025 1.34%
Mar 31, 2025 -12.31%
Dec 31, 2024 17.34%
Sep 30, 2024 11.28%
Jun 30, 2024 12.59%
Mar 31, 2024 10.80%
Dec 31, 2023 8.53%
Sep 30, 2023 26.62%
Jun 30, 2023 21.78%
Mar 31, 2023 20.96%
Dec 31, 2022 29.28%
Sep 30, 2022 12.00%
Jun 30, 2022 3.16%
Mar 31, 2022 3.93%
Dec 31, 2021 -22.87%
Sep 30, 2021 -10.42%
Jun 30, 2021 2.93%
Mar 31, 2021 17.15%
Dec 31, 2020 44.49%
Sep 30, 2020 25.82%
Jun 30, 2020 3.37%
Mar 31, 2020 -4.40%
Dec 31, 2019 -4.07%
Sep 30, 2019 -9.96%
Jun 30, 2019 16.02%
Mar 31, 2019 1.63%
Dec 31, 2018 -1.20%
Sep 30, 2018 6.69%
Jun 30, 2018 1.19%
Mar 31, 2018 -19.61%
Dec 31, 2017 -14.43%
Sep 30, 2017 -12.41%
Jun 30, 2017 -8.33%
Mar 31, 2017 21.91%
Dec 31, 2016 23.83%
Sep 30, 2016 28.32%
Jun 30, 2016 33.33%
Mar 31, 2016 57.86%
Dec 31, 2015 64.34%
Sep 30, 2015 63.77%
Jun 30, 2015 56.82%
Mar 31, 2015 82.76%
Dec 31, 2014 116.67%
Sep 30, 2014 109.09%
Jun 30, 2014 106.25%
Mar 31, 2014 74.00%
Dec 31, 2013 46.67%
Sep 30, 2013 34.69%
Jun 30, 2013 33.33%
Mar 31, 2013 21.95%
Dec 31, 2012 26.16%
Sep 30, 2012 32.43%
Jun 30, 2012 33.33%
Mar 31, 2012 64.00%
Dec 31, 2011 75.11%
Sep 30, 2011 59.69%